| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sera Prognostics, Inc. (SERA) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. SERA is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 822.9K | $1.32M | - | |
| CEO | 738.3K | $1.18M | - | |
| CFO | 264.5K | $423.1K | - | |
| Other | 164.0K | $262.3K | - | |
| Other | 145.8K | $233.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Mirza Mansoor Raza82 | Director | Sell | 222 | $3.35 | $743.70 | -0.4% | -10.8% | - | |
| Sep 2, 2025 | Kearney Paul82 | Chief Data Officer | Sell | 1,458 | $3.49 | $5,088.42 | -0.8% | -3.6% | - | |
| Aug 29, 2025 | Kearney Paul82 | Chief Data Officer | Sell | 10,542 | $3.49 | $36,791.58 | -5.6% | +3.1% | - | |
| Aug 20, 2025 | Harrison Robert Gardner76 | Chief Information Officer | Sell | 6,000 | $2.22 | $13,320.00 | -5.5% | +38.7% | - | |
| Aug 8, 2025 | Aerts Austin82 | Chief Financial Officer | Sell | 5,800 | $2.54 | $14,732.00 | -2.0% | +8.9% | - | |
| Aug 8, 2025 | Lindgardt Zhenya81 | Chief Executive Officer | Sell | 8,571 | $2.54 | $21,770.34 | -1.0% | +8.9% | - | |
| Aug 8, 2025 | Kearney Paul82 | Chief Data Officer | Sell | 6,460 | $2.54 | $16,408.40 | -3.3% | +8.9% | - | |
| Aug 8, 2025 | Jackson Benjamin83 | General Counsel | Sell | 6,447 | $2.54 | $16,375.38 | -4.8% | +8.9% | - | |
| Aug 8, 2025 | Harrison Robert Gardner76 | Chief Information Officer | Sell | 5,962 | $2.54 | $15,143.48 | -5.2% | +8.9% | - | |
| Aug 8, 2025 | Boniface John J.55 | Chief Scientific Officer | Sell | 7,094 | $2.54 | $18,018.76 | -4.2% | +8.9% | - |